39 related articles for article (PubMed ID: 38501247)
1. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
Li Q; Han X; Lan X; Hong X; Li Q; Gao Y; Luo T; Yang Q; Koehler RC; Zhai Y; Zhou J; Wang J
Neurobiol Dis; 2017 Dec; 108():173-182. PubMed ID: 28830843
[TBL] [Abstract][Full Text] [Related]
2. Effects of Lithium Ions on tPA-Induced Hemorrhagic Transformation under Stroke.
Babenko VA; Yakupova EI; Pevzner IB; Bocharnikov AD; Zorova LD; Fedulova KS; Grebenchikov OA; Kuzovlev AN; Grechko AV; Silachev DN; Rahimi-Moghaddam P; Plotnikov EY
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927532
[TBL] [Abstract][Full Text] [Related]
3. ADAMTS13 deficiency exacerbates neuroinflammation by targeting matrix metalloproteinase-9 in ischemic brain injury.
Jiang H; Hu J; He P; Wu Y; Li F; Chen Q
Neuroreport; 2024 May; 35(7):447-456. PubMed ID: 38597325
[TBL] [Abstract][Full Text] [Related]
4. Physiologic variations in blood plasminogen levels affect outcomes after acute cerebral thromboembolism in mice: a pathophysiologic role for microvascular thrombosis.
Singh S; Houng AK; Wang D; Reed GL
J Thromb Haemost; 2016 Sep; 14(9):1822-32. PubMed ID: 27319402
[TBL] [Abstract][Full Text] [Related]
5. Development of endothelial-targeted CD39 as a therapy for ischemic stroke.
Lee NT; Savvidou I; Selan C; Calvello I; Vuong A; Wright DK; Brkljaca R; Willcox A; Chia JSJ; Wang X; Peter K; Robson SC; Medcalf RL; Nandurkar HH; Sashindranath M
J Thromb Haemost; 2024 May; ():. PubMed ID: 38754782
[TBL] [Abstract][Full Text] [Related]
6. A matrix metalloproteinase-responsive hydrogel system controls angiogenic peptide release for repair of cerebral ischemia/reperfusion injury.
Liu Q; Xie J; Zhou R; Deng J; Nie W; Sun S; Wang H; Shi C
Neural Regen Res; 2025 Feb; 20(2):503-517. PubMed ID: 38819063
[TBL] [Abstract][Full Text] [Related]
7. Critical Care Management of Acute Ischemic Stroke.
Bevers MB; Kimberly WT
Curr Treat Options Cardiovasc Med; 2017 Jun; 19(6):41. PubMed ID: 28466119
[TBL] [Abstract][Full Text] [Related]
8. Sodium-Glucose Cotransporter 2 Inhibitor Improves Neurological Outcomes in Diabetic Patients With Acute Ischemic Stroke.
Yang W; Kim JM; Chung M; Ha J; Kang DW; Lee EJ; Jeong HY; Jung KH; Sung H; Paeng JC; Lee SH
J Stroke; 2024 May; 26(2):342-346. PubMed ID: 38836284
[No Abstract] [Full Text] [Related]
9. Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process.
Munno M; Mallia A; Greco A; Modafferi G; Banfi C; Eligini S
Antioxidants (Basel); 2024 May; 13(5):. PubMed ID: 38790688
[TBL] [Abstract][Full Text] [Related]
10. Neural Stem Cell-Derived Small Extracellular Vesicles: key Players in Ischemic Stroke Therapy - A Comprehensive Literature Review.
Zhu Z; Zhang Q; Feng J; Zebaze Dongmo S; Zhang Q; Huang S; Liu X; Zhang G; Chen L
Int J Nanomedicine; 2024; 19():4279-4295. PubMed ID: 38766658
[TBL] [Abstract][Full Text] [Related]
11. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
12. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
Suzuki Y; Nagai N; Umemura K
J Pharmacol Sci; 2011; 116(1):25-9. PubMed ID: 21498957
[TBL] [Abstract][Full Text] [Related]
13. Role of tissue-type plasminogen activator in ischemic stroke.
Suzuki Y
J Pharmacol Sci; 2010; 113(3):203-7. PubMed ID: 20595786
[TBL] [Abstract][Full Text] [Related]
14. LOX-1 and MMP-9 Inhibition Attenuates the Detrimental Effects of Delayed rt-PA Therapy and Improves Outcomes After Acute Ischemic Stroke.
Arkelius K; Wendt TS; Andersson H; Arnou A; Gottschalk M; Gonzales RJ; Ansar S
Circ Res; 2024 Apr; 134(8):954-969. PubMed ID: 38501247
[TBL] [Abstract][Full Text] [Related]
15. Ozanimod differentially preserves human cerebrovascular endothelial barrier proteins and attenuates matrix metalloproteinase-9 activity following in vitro acute ischemic injury.
Wendt TS; Gonzales RJ
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C951-C971. PubMed ID: 37642239
[TBL] [Abstract][Full Text] [Related]
16. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
